CNR Institutional Research Information System

VIGLIETTO, GIUSEPPE

VIGLIETTO, GIUSEPPE  

Istituto di Endocrinologia e Oncologia Sperimentale ''G. Salvatore'' - IEOS  

Mostra records
Risultati 1 - 20 di 44 (tempo di esecuzione: 0.074 secondi).
Titolo Data di pubblicazione Autore(i) File
A mutated p53 gene alters thyroid cell differentiation. 1-gen-1995 Battista S; Martelli ML; Fedele M; Chiappetta G; Trapasso F; De Vita G; Battaglia C; Santoro M; Viglietto G; Fagin JA;Fusco A.
A new mechanism of BRAF activation in human thyroid papillary carcinomas. 1-gen-2005 Fusco, A; Viglietto, G; Santoro, M
A truncated form of teratocarcinoma-derived growth factor-1 (cripto-1) mRNA expressed in human colon carcinoma cell lines and tumors. 1-gen-2001 Baldassarre G; Tucci M; Lembo G; Pacifico FM; Dono R; Lago CT; Barra A; Bianco C; Viglietto G; Salomon D; Persico MG.
A truncated HMGA1 gene induces proliferation of the 3T3-L1 pre-adipocytic cells: a model of human lipomas. 1-gen-2003 Pierantoni, Gm; Battista, S; Pentimalli, F; Fedele, M; Visone, R; Federico, A; Santoro, M; Viglietto, G; Fusco, A
Akt-dependent T198 phosphorylation of cicli-dependent kinase inhibitor p27kip1 in breast cancer. 1-gen-2004 Motti, Ml; De Marco, C; Califano, D; Fusco, A; Viglietto, G
An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo. 1-gen-2003 Iuliano, R; Trapasso, F; Le Pera, I; Schepis, F; Sama, I; Clodomiro, A; Dumon, Kr; Santoro, M; Chiariotti, L; Viglietto, G; Fusco, A
Characterization of 2 novel and 2 recurring BRCA1 germline mutations in breast and/or ovarian carcinoma patients from Naples area 1-gen-2001 A Curci; I Capasso; P Bruni; M DUrso; G DAiuto; S Pignata; A Fusco;G Viglietto
Characterization of 2 novel and 2 recurring BRCA1 germline mutations in breast and/or ovarian carcinoma patients from the area of Naples. 1-gen-2002 Curci, A; Capasso, I; Romano, A; Bruni, P; Motti, Ml; Pignata, S; D'Aiuto, G; Casamassimi, A; D'Urso, M; Fusco, A; Viglietto, G
Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization. 1-gen-2005 Motti, Ml; Califano, D; Troncone, G; De Marco, C; Migliaccio, I; Palmieri, E; Pezzullo, L; Palombini, L; Fusco, A; Viglietto, G
Critical role of cyclin D3 in TSH-dependent growth of thyrocytes and in hyperproliferative diseases of the thyroid gland. 1-gen-2003 Motti, Ml; Boccia, A; Belletti, B; Bruni, P; Troncone, G; Cito, L; Monaco, M; Chiappetta, G; Baldassarre, G; Palombini, L; Fusco, A; Viglietto, G
Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation. 1-gen-2001 Melillo, Rm; Pierantoni, Gm; Scala, S; Battista, S; Fedele, M; Stella, A; De Biasio, Mc; Chiappetta, G; Fidanza, V; Condorelli, G; Santoro, M; Croce, Cm; Viglietto, G; Fusco, A
Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. 1-gen-2002 Viglietto, G; Motti, Ml; Bruni, P; Melillo, Rm; D'Alessio, A; Califano, D; Vinci, F; Chiappetta, G; Tsichlis, P; Bellacosa, A; Fusco, A; Santoro, M
DREAM is a transcriptional repressor involved in thyroid differentiation and function 1-gen-2003 Dandrea, B; Di Palma, T; Macchia, Pe; Terracciano, D; Motti, Ml; Viglietto, G; Mascia, A; Macchia, V; Di Lauro, R; Zannini, M
Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27(kip1). 1-gen-2002 Baldassarre G. ; Bruni P. ; Boccia A. ; Salvatore G. ; Melillo R.M. ; Motti M.L. ; Napolitano M. ; Belletti B. ; Fusco A. ; Santoro M. ; Viglietto G.
High Mobility Group (HMGA1a) protein expression as a diagnostic indicator of human colorectal neoplastic diseases 1-gen-2002 G. Chiappetta; G. Manfioletti; F. Pentimalli; M. Molnaco; R. Pasquinelli; T. Watanabe; M. Fedele; G. Viglietto; M. Santoro; V. Giancotti A. Fusco
High mobility group A1 expression correlates with the histological grade of human glial tumors. 1-gen-2004 Donato, G; Martinez Hoyos, J; Amorosi, A; Maltese, L; Lavano, A; Volpentesta, G; Signorelli, F; Pentimalli, F; Pallante, P; Ferraro, G; Tucci, L; Signorelli, Cd; Viglietto, G; Fusco, A
High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth. 1-gen-2001 Pierantoni G.M. ; Fedele M. ; Pentimalli F. ; Benvenuto G. ; Pero R.; Viglietto G. ; Santoro M. ; Chiariotti L. ; Fusco A.
High Mobility Group I proteins in adipocytic cell transformation. 1-gen-1999 Fusco A; Battista S; Fidanza V; Fedele M; Chiappetta G; Scala S; Melillo; R M; Stella A; Pierantoni; M G; Santoro M; Croce; C M;Viglietto; G
High-Mobility-Group protein I(Y) as potential tumour marker in Human Colorectal Carcinomas. 1-gen-1995 Chiappetta, G; Bandiera, A; Fedele, M; Battista, S; Manfioletti, G; Viglietto, G; Casamassimi, A; Santoro, M; Giancotti, V; Fusco, Alfredo; A,
HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas. 1-gen-2003 Masciullo V. ; Baldassarre G. ; Pentimalli F. ; Berlingieri M.T. ; Boccia A. ; Chiappetta G. ; Palazzo J. ; Manfioletti G. ; Giancotti V. ; Viglietto G. ; Scambia G. ; Fusco A.